Literature DB >> 29552439

The natural history of hereditary motor and sensory neuropathy with proximal dominant involvement (HMSN-P) in 97 Japanese patients.

Natsumi Fujisaki1, Shugo Suwazono1,2, Masahito Suehara3, Ryo Nakachi1, Miwako Kido1, Yoshihisa Fujiwara1, Saki Oshiro1, Takashi Tokashiki1, Hiroshi Takashima4, Masanori Nakagawa5.   

Abstract

Hereditary motor and sensory neuropathy with proximal dominant involvement (HMSN-P) is a motor and sensory neuronopathy with autosomal dominant inheritance, adult onset, slowly progressive course, and is associated with TRK-fused gene (TFG) mutation. At advanced stages, respiratory failure and dysphagia becomes life-threatoning, and patients typically die by their 70s. Although there is currently no evidence for effective treatment, a therapy may be found by elucidation of the function of TFG. Recently its pathomechanism has been proposed to be associated with abnormalities in protein transfer from the endoplasmic reticulum. Such pathomechanisms might involve a similar process in amyotrophic lateral sclerosis; thus, its pathomechanisms and treatment strategy might make it a good model for neurodegenerative disorders. It is of great value to clarify the natural history of HMSN-P, in oder to judge the treatment effect. By evaluating 97 patients (79 out of 97 were examined and all confirmed with p.Pro 285 Leu mutation) in this study, it was confirmed that this disease follows a uniform course in the earlier stages, and there are individual differences in the onset between 20 and 30 years. Such uniformity might be due to the proposed single gene abnormality. At advanced stages, there are larger individual differences in the progression, but the reasons for these are unknown. Longer survival might be achieved with a better care for respiratory failure and dysphagia if such cares were undertaken at appropriate times.

Entities:  

Keywords:  HMSN Okinawa type; TRK-fused gene; natural history

Year:  2018        PMID: 29552439      PMCID: PMC5849632          DOI: 10.5582/irdr.2017.01084

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  14 in total

1.  HMSN-P caused by p.Pro285Leu mutation in TFG is not confined to patients with Far East ancestry.

Authors:  Afagh Alavi; Hosein Shamshiri; Shahriar Nafissi; Marzieh Khani; Brandy Klotzle; Jian-Bing Fan; Frank Steemers; Elahe Elahi
Journal:  Neurobiol Aging       Date:  2014-12-16       Impact factor: 4.673

Review 2.  Novel approaches in anaplastic thyroid cancer therapy.

Authors:  Kun-Tai Hsu; Xiao-Min Yu; Anjon W Audhya; Juan C Jaume; Ricardo V Lloyd; Shigeki Miyamoto; Tomas A Prolla; Herbert Chen
Journal:  Oncologist       Date:  2014-09-26

3.  TFG facilitates outer coat disassembly on COPII transport carriers to promote tethering and fusion with ER-Golgi intermediate compartments.

Authors:  Michael G Hanna; Samuel Block; E B Frankel; Feng Hou; Adam Johnson; Lin Yuan; Gavin Knight; James J Moresco; John R Yates; Randolph Ashton; Randy Schekman; Yufeng Tong; Anjon Audhya
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-29       Impact factor: 11.205

4.  The calcium-binding protein ALG-2 promotes endoplasmic reticulum exit site localization and polymerization of Trk-fused gene (TFG) protein.

Authors:  Takashi Kanadome; Hideki Shibata; Keiko Kuwata; Terunao Takahara; Masatoshi Maki
Journal:  FEBS J       Date:  2016-11-29       Impact factor: 5.542

5.  A novel TFG mutation causes Charcot-Marie-Tooth disease type 2 and impairs TFG function.

Authors:  Pei-Chien Tsai; Yen-Hua Huang; Yuh-Cherng Guo; Hung-Ta Wu; Kon-Ping Lin; Yu-Shuen Tsai; Yi-Chu Liao; Yo-Tsen Liu; Tze-Tze Liu; Lung-Sen Kao; Shaw-Fang Yet; Ming-Ji Fann; Bing-Wen Soong; Yi-Chung Lee
Journal:  Neurology       Date:  2014-08-06       Impact factor: 9.910

6.  [Pathomechanisms of motor neuron death by mutant TFG].

Authors:  Toshitaka Kawarai; Mitsuya Morita; Ryoma Morigaki; Koji Fujita; Hiroyuki Nodera; Yuishin Izumi; Satoshi Goto; Imaharu Nakano; Ryuji Kaji
Journal:  Rinsho Shinkeigaku       Date:  2013

7.  The TRK-fused gene is mutated in hereditary motor and sensory neuropathy with proximal dominant involvement.

Authors:  Hiroyuki Ishiura; Wataru Sako; Mari Yoshida; Toshitaka Kawarai; Osamu Tanabe; Jun Goto; Yuji Takahashi; Hidetoshi Date; Jun Mitsui; Budrul Ahsan; Yaeko Ichikawa; Atsushi Iwata; Hiide Yoshino; Yuishin Izumi; Koji Fujita; Kouji Maeda; Satoshi Goto; Hidetaka Koizumi; Ryoma Morigaki; Masako Ikemura; Naoko Yamauchi; Shigeo Murayama; Garth A Nicholson; Hidefumi Ito; Gen Sobue; Masanori Nakagawa; Ryuji Kaji; Shoji Tsuji
Journal:  Am J Hum Genet       Date:  2012-08-10       Impact factor: 11.025

Review 8.  The changing scene of amyotrophic lateral sclerosis.

Authors:  Wim Robberecht; Thomas Philips
Journal:  Nat Rev Neurosci       Date:  2013-03-06       Impact factor: 34.870

9.  Proteasome impairment in neural cells derived from HMSN-P patient iPSCs.

Authors:  Nagahisa Murakami; Keiko Imamura; Yuishin Izumi; Naohiro Egawa; Kayoko Tsukita; Takako Enami; Takuya Yamamoto; Toshitaka Kawarai; Ryuji Kaji; Haruhisa Inoue
Journal:  Mol Brain       Date:  2017-02-15       Impact factor: 4.041

10.  Trk-fused gene (TFG) regulates pancreatic β cell mass and insulin secretory activity.

Authors:  Takeshi Yamamotoya; Yusuke Nakatsu; Akifumi Kushiyama; Yasuka Matsunaga; Koji Ueda; Yuki Inoue; Masa-Ki Inoue; Hideyuki Sakoda; Midori Fujishiro; Hiraku Ono; Hiroshi Kiyonari; Hisamitsu Ishihara; Tomoichiro Asano
Journal:  Sci Rep       Date:  2017-10-12       Impact factor: 4.379

View more
  1 in total

Review 1.  Clinical genetics of Charcot-Marie-Tooth disease.

Authors:  Yujiro Higuchi; Hiroshi Takashima
Journal:  J Hum Genet       Date:  2022-03-18       Impact factor: 3.755

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.